Expert: Lens Recall Impact Rests With FDA

The GMP Letter
CooperVision’s recent expansion of a contact lens recall will have long-term negative effects only if FDA investigations turn up other significant problems, contact lens consultant Ralph Stone said in a Nov. 16 Wells Fargo Securities conference call.

To View This Article:


Subscribe To The GMP Letter

Buy This Article Now

Add this article to your cart for $40.00